Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
The U.S. Food and Drug Administration (FDA) recently accepted an Investigational New Drug (IND) application for tazemetostat as a potential treatment of mesothelioma ... Read more
Pin It on Pinterest